Reich, K., Blauvelt, A., Thaci, D., Leonardi, C., Poulin, Y., Burge, D., Peterson, L., Arendt, C., & Gottlieb, A. B. (2017). Maintenance of Response with Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: 48-Week Results from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine, 1(3.1), s23.